Why Most Healthcare AI Pilots Never Reach Production

The pattern repeats across health systems worldwide: an AI pilot demonstrates impressive accuracy on retrospective data, gets clinician enthusiasm, then dies in the gap between pilot and production. Several factors drive this. Regulatory clearance: in the US, AI tools that influence clinical decisions usually require FDA clearance, a process that takes 12 to 24 months and demands rigorous validation evidence. EHR integration: getting AI outputs into Epic, Cerner, or Meditech workflows requires technical integration through HL7 FHIR APIs and clinical content reviews. Without integration, clinicians won't use the tool no matter how good it is. Workflow fit: an AI that flags abnormalities is useful only if the alert lands at the right person at the right time. Poorly designed alerts cause alert fatigue and get ignored or disabled. Reimbursement: many AI tools improve outcomes but don't have a billing code, so hospitals can't recover the cost of using them. Liability: when an AI gives a recommendation a clinician accepts, who's responsible if it's wrong? Legal departments often slow adoption pending clarity. Bias and equity audits: tools must be validated across the demographic groups in the deploying hospital's population, not just the dataset they were trained on. Successful healthcare AI deployments — like sepsis prediction at Kaiser Permanente or stroke detection through Viz.ai — share common patterns: tight EHR integration, clear clinical workflows, FDA clearance where required, and disciplined post-deployment monitoring. Building the model is maybe 20 percent of the work. The other 80 percent is everything that gets you from pilot to actually changing clinical care.